DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder

Phase 2

Recruiting

Conditions: Autism Spectrum Disorder

Interventions: Drug: Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID]
Drug: Placebo

First Posted Date: 2023-08-21

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 30

Registration Number: NCT05999240

Locations: 🇺🇸
Wakarusa Research Facility, Lawrence, Kansas, United States
🇺🇸
Center for Autism and the Developing Brain, White Plains, New York, United States

Sleep Interventions and Neurocognitive Outcomes

Not Applicable

Not yet recruiting

Conditions: Amnestic Mild Cognitive Impairment
Sleep Disturbance

Interventions: Device: Acoustic slow-wave activity enhancement
Behavioral: Cognitive behavioral therapy for insomnia

First Posted Date: 2023-08-14

Last Posted Date: 2025-04-09

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 50

Registration Number: NCT05987007

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

Not Applicable

Not yet recruiting

Conditions: Cocaine Use
Cocaine Use Disorder
Cocaine Use Disorder, Moderate
Cocaine Dependence
Cocaine Use Disorder, Severe

Interventions: Device: Active H7-coil repetitive transcranial magnetic stimulation (rTMS)
Device: Sham H7-coil repetitive transcranial magnetic stimulation (rTMS)

First Posted Date: 2023-08-03

Last Posted Date: 2025-05-06

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 30

Registration Number: NCT05974202

Locations: 🇺🇸
New York State Psychiatric Institute (NYSPI) / Substance Treatment and Research Service (STARS), New York, New York, United States

Effects of rTMS on Food Choice in Anorexia Nervosa

Not Applicable

Suspended

Conditions: Anorexia Nervosa

Interventions: Device: High-frequency repetitive transcranial magnetic stimulation (active rTMS)
Device: Sham repetitive transcranial magnetic stimulation (sham rTMS)

First Posted Date: 2023-06-26

Last Posted Date: 2024-08-19

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 72

Registration Number: NCT05918835

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Reducing Self-stigma Using Brief Video Intervention

Not Applicable

Completed

Conditions: Stigma, Social
Mental Health Disorder

Interventions: Behavioral: video

First Posted Date: 2023-05-26

Last Posted Date: 2023-05-26

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 1214

Registration Number: NCT05878470

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

A Pilot Study of SPG Block for PTSD

Early Phase 1

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Other: Sphenopalatine ganglion block

First Posted Date: 2023-02-24

Last Posted Date: 2024-02-16

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 6

Registration Number: NCT05743543

Locations: 🇺🇸
NYSPI, New York, New York, United States

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Phase 1

Recruiting

Conditions: Opioid Withdrawal
Opioid Use Disorder

Interventions: Drug: BXCL501 (240 micrograms)
Other: Placebo
Drug: BXCL501 (180 micrograms)
Other: Lofexidine (Positive Control)

First Posted Date: 2023-02-03

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 160

Registration Number: NCT05712707

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Clinilabs, Eatontown, New Jersey, United States
🇺🇸
CenExel HRI, Marlton, New Jersey, United States

and more 1 locations

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

Phase 2

Active, not recruiting

Conditions: Cognitive Dysfunction
Post-acute Sequelae of COVID-19
Depressive Symptoms

Interventions: Drug: CI-581a
Drug: CI-581b

First Posted Date: 2023-01-19

Last Posted Date: 2024-07-16

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 12

Registration Number: NCT05690503

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Tailoring Overdose Education for Black Churches

Not Applicable

Suspended

Conditions: Opioid Overdose

Interventions: Behavioral: COEST

First Posted Date: 2022-12-09

Last Posted Date: 2024-08-22

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 96

Registration Number: NCT05645016

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Repeated Administration of Cannabis Varying in THC and CBD

Phase 2

Suspended

Conditions: Cannabis

Interventions: Drug: Cannabis

First Posted Date: 2022-10-03

Last Posted Date: 2024-12-16

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 100

Registration Number: NCT05563948

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy